Trials / Completed
CompletedNCT04039373
Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil
An Open-label, Single-sequence Study to Investigate the Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Study to Investigate BMS-986256 at steady state and its effect on Mycophenolate Mofetil exposure in Healthy Male Participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986256 | specified dose on specified days |
| DRUG | Mycophenolate Mofetil | specified dose on specified days |
Timeline
- Start date
- 2019-07-22
- Primary completion
- 2019-09-18
- Completion
- 2019-10-16
- First posted
- 2019-07-31
- Last updated
- 2020-06-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04039373. Inclusion in this directory is not an endorsement.